UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 92

Sortiert nach

NEAT1-TFE3 and KAT6A-TFE3 renal cell carcinomas, new members of MiT family translocation renal cell carcinoma

Modern pathology, 2019-05, Vol.32 (5), p.710-716

2019

Volltextzugriff (PDF)

PBRM1 acts as a p53 lysine-acetylation reader to suppress renal tumor growth

Nature communications, 2019-12, Vol.10 (1), p.5800-15, Article 5800

2019

Volltextzugriff (PDF)

A phase 1 study of nivolumab in combination with interferon-gamma for patients with advanced solid tumors

Nature communications, 2023-07, Vol.14 (1), p.4513-4513, Article 4513

2023

Volltextzugriff (PDF)

Mutational patterns in chemotherapy resistant muscle-invasive bladder cancer

Nature communications, 2017-12, Vol.8 (1), p.2193-11, Article 2193

2017

Volltextzugriff (PDF)

Prognostic impact of immune gene expression signature and tumor infiltrating immune cells in localized clear cell renal cell carcinoma

Journal for immunotherapy of cancer, 2019-05, Vol.7 (1), p.139-139, Article 139

2019

Volltextzugriff (PDF)

Case report: reinitiating pembrolizumab treatment after small bowel perforation

BMC cancer, 2019-04, Vol.19 (1), p.379-379, Article 379

2019

Volltextzugriff (PDF)

Alterations of NK Cell Phenotype in the Disease Course of Multiple Myeloma

Cancers, 2021-01, Vol.13 (2), p.226

2021

Volltextzugriff (PDF)

Impacts of pembrolizumab therapy on immune phenotype in patients with high-grade neuroendocrine neoplasms

Cancer Immunology, Immunotherapy, 2021-07, Vol.70 (7), p.1893-1906

2021

Volltextzugriff (PDF)

Multiple tumor suppressors regulate a HIF-dependent negative feedback loop via ISGF3 in human clear cell renal cancer

eLife, 2018-10, Vol.7

2018

Volltextzugriff (PDF)

Musashi-2 (MSI2) regulates epidermal growth factor receptor (EGFR) expression and response to EGFR inhibitors in EGFR-mutated non-small cell lung cancer (NSCLC)

Oncogenesis (New York, NY), 2021-03, Vol.10 (3), p.29-29, Article 29

2021

Volltextzugriff (PDF)

Correction: Multiple tumor suppressors regulate a HIF-dependent negative feedback loop via ISGF3 in human clear cell renal cancer

eLife, 2021-04, Vol.10

2021

Volltextzugriff (PDF)

Pak2 restrains endomitosis during megakaryopoiesis and alters cytoskeleton organization

Blood, 2015-05, Vol.125 (19), p.2995-3005

2015

Volltextzugriff (PDF)

Porcine intact and wounded skin responses to atmospheric nonthermal plasma

The Journal of surgical research, 2013, Vol.179 (1), p.e1-e12

2013

Volltextzugriff (PDF)

Lymphocyte Exhaustion in AML Patients and Impacts of HMA/Venetoclax or Intensive Chemotherapy on Their Biology

Cancers, 2022-07, Vol.14 (14), p.3352

2022

Volltextzugriff (PDF)

Coexisting Hybrid Malignancy in a Solitary Sporadic Solid Benign Renal Mass: Implications for Treating Patients Following Renal Biopsy

The Journal of urology, 2014-02, Vol.191 (2), p.296-300

2014

Volltextzugriff (PDF)

Immunohistochemistry Successfully Uncovers Intratumoral Heterogeneity and Widespread Co-Losses of Chromatin Regulators in Clear Cell Renal Cell Carcinoma

PloS one, 2016-10, Vol.11 (10), p.e0164554

2016

Volltextzugriff (PDF)

Identification of novel target genes by an epigenetic reactivation screen of renal cancer

Cancer research (Chicago, Ill.), 2006-05, Vol.66 (10), p.5021-5028

2006

Volltextzugriff (PDF)

Tumor Suppressor Gene Promoter Hypermethylation in Serum of Breast Cancer Patients

Clinical cancer research, 2004-09, Vol.10 (18), p.6189-6193

2004

Volltextzugriff (PDF)

Tumor cell-specific BRCA1 and RASSF1A hypermethylation in serum, plasma, and peritoneal fluid from ovarian cancer patients

Cancer research (Chicago, Ill.), 2004-09, Vol.64 (18), p.6476-6481

2004

Volltextzugriff (PDF)

Matrix-regulated integrin αvβ5 maintains α5β1-dependent desmoplastic traits prognostic of neoplastic recurrence

eLife, 2017-01, Vol.6

2017

Volltextzugriff (PDF)

Lymphopenia is an independent predictor of inferior outcome in papillary renal cell carcinoma

Urologic oncology, 2015-09, Vol.33 (9), p.388.e19-388.e25

2015

Volltextzugriff (PDF)

Detection of Bladder Cancer in Urine by a Tumor Suppressor Gene Hypermethylation Panel

Clinical cancer research, 2004-03, Vol.10 (6), p.1887-1893

2004

Volltextzugriff (PDF)

Metastatic Extramammary Paget’s Disease of Scrotum Responds Completely to Single Agent Trastuzumab in a Hemodialysis Patient: Case Report, Molecular Profiling and Brief Review of the Literature

Case reports in oncological medicine, 2015-01, Vol.2015, p.895151-7

2015

Volltextzugriff (PDF)

A global profile of gene promoter methylation in treatment-naïve urothelial cancer

Epigenetics, 2014-05, Vol.9 (5), p.760-773

2014

Volltextzugriff (PDF)

T-Prolymphocytic Leukemia Presenting as Lymphadenopathy and no Lymphocytosis

American journal of clinical pathology, 2014-10, Vol.142 (suppl_1), p.A107-A107

2014

Volltextzugriff (PDF)

1 – 25 von 92

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(85)
Mit Volltextzugriff
(76)

Publikationsform

Sprache

Englisch
(92)
Japanisch
(15)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

NEAT1-TFE3 and KAT6A-TFE3 renal cell carcinomas, new members of MiT family translocation renal cell carcinoma

PBRM1 acts as a p53 lysine-acetylation reader to suppress renal tumor growth

A phase 1 study of nivolumab in combination with interferon-gamma for patients with advanced solid tumors

Mutational patterns in chemotherapy resistant muscle-invasive bladder cancer

Prognostic impact of immune gene expression signature and tumor infiltrating immune cells in localized clear cell renal cell carcinoma

Case report: reinitiating pembrolizumab treatment after small bowel perforation

Alterations of NK Cell Phenotype in the Disease Course of Multiple Myeloma

Impacts of pembrolizumab therapy on immune phenotype in patients with high-grade neuroendocrine neoplasms

Multiple tumor suppressors regulate a HIF-dependent negative feedback loop via ISGF3 in human clear cell renal cancer

Musashi-2 (MSI2) regulates epidermal growth factor receptor (EGFR) expression and response to EGFR inhibitors in EGFR-mutated non-small cell lung cancer (NSCLC)

Correction: Multiple tumor suppressors regulate a HIF-dependent negative feedback loop via ISGF3 in human clear cell renal cancer

Pak2 restrains endomitosis during megakaryopoiesis and alters cytoskeleton organization

Porcine intact and wounded skin responses to atmospheric nonthermal plasma

Lymphocyte Exhaustion in AML Patients and Impacts of HMA/Venetoclax or Intensive Chemotherapy on Their Biology

Coexisting Hybrid Malignancy in a Solitary Sporadic Solid Benign Renal Mass: Implications for Treating Patients Following Renal Biopsy

Immunohistochemistry Successfully Uncovers Intratumoral Heterogeneity and Widespread Co-Losses of Chromatin Regulators in Clear Cell Renal Cell Carcinoma

Identification of novel target genes by an epigenetic reactivation screen of renal cancer

Tumor Suppressor Gene Promoter Hypermethylation in Serum of Breast Cancer Patients

Tumor cell-specific BRCA1 and RASSF1A hypermethylation in serum, plasma, and peritoneal fluid from ovarian cancer patients

Matrix-regulated integrin αvβ5 maintains α5β1-dependent desmoplastic traits prognostic of neoplastic recurrence

Lymphopenia is an independent predictor of inferior outcome in papillary renal cell carcinoma

Detection of Bladder Cancer in Urine by a Tumor Suppressor Gene Hypermethylation Panel

Metastatic Extramammary Paget’s Disease of Scrotum Responds Completely to Single Agent Trastuzumab in a Hemodialysis Patient: Case Report, Molecular Profiling and Brief Review of the Literature

A global profile of gene promoter methylation in treatment-naïve urothelial cancer

T-Prolymphocytic Leukemia Presenting as Lymphadenopathy and no Lymphocytosis

Suchergebnisse filtern